Skip to main navigation Skip to main content Skip to page footer

Παρεμβατικό πρόγραμμα μη φαρμακευτικής αντιμετώπισης της Υπέρτασης

ΒΙΒΛΙΟΓΡΑΦΙΑ

  1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42: 1206–1252.
  2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
  3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-23.
  4. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008, 371(9623):1513-8.
  5. Panagiotakos DB, Chrysohoou C, Pitsavos C, et al. Hierarchical analysis of anthropometric indices in the prediction of 5-year incidence of hypertension in apparently healthy adults: the ATTICA study. Atherosclerosis 2009, 206(1):314-20.
  6. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004, 33(6):1345-52.
  7. Efstratopoulos AD, Voyaki SM, Baltas AA, et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006, 19(1):53-60.
  8. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 2001, 37:187–193.
  9. Omvik P. How smoking effects blood pressure. Blood Pressure 1996, 5:71–77.
  10.  Pubbey IB, Parker M, Beilin LJ, Vandongen R, Masarei JR. Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men. Hypertension 1992, 20:533–541.
  11.  Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of non-pharmacological interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998, 279:839–8467.
  12.  Law MR. Epidemiological evidence of salt and blood pressure. Am J Hypertens 1997, 10 (Suppl. 5): S42–S45.
  13.  Cutler JA, Follman D, Alexander PS. Randomised controlled trials of sodium reduction: an overview. Am J Clin Nutr 1997, 65 (Suppl. 2):S643–S651.
  14.  Beckmann SL, Os I, Kjeldsen SE, Eide IK, Westheim AS, Hjermann I. Effect of dietary counseling on blood pressure and arterial plasma catecholamines in primary hypertension. Am J Hypertens 1995, 8:704–711.
  15.  Margetts BM, Beilin LJ, Vandongen R, Armstrong BK. Vegetarian diet in mild hypertension: a randomized controlled trial. British Medical Journal 1986, 293:1468–1471.
  16.  Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 1996, 27:1033–1039.
  17.  He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors Associated With Hypertension Control in the General Population of the United States. Arch Intern Med 2002, 162:1051-1058.
  18.  Mancia G. Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105–1187.
  19.  Sparrenberger F, Cichelero FT, Ascoli AM, et al. Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens 2009, 23(1):12-9.
  20.  Steptoe A. Psychophysiological stress reactivity and hypertension. Hypertension 2008, 52(2):220-1.
  21.  Khan NA, Hemmelgarn B, Herman RJ, et al; Canadian Hypertension Education Program. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2–therapy. Can J Cardiol 2009, 25(5):287-98.
  22.  Brook RD et al; Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure. A Scientific Statement From the American Heart Association. Hypertension. 2013;61:00-00.
  23.  Nakao M, Nomura S, Shimosawa T, Fujita T, Kuboki T. Blood pressure biofeedback treatment of white-coat hypertension. J Psychosom Res 2000, 48:161-169.
  24.  Achmon J, Granek M, Golomb M, Hart J. Behavioral treatment of essential hypertension: a comparison between cognitive therapy and biofeedback of heart rate. Psychosom Med 1989, 51:152-164.
  25.  Yucha CB, Tsai PS, Calderon KS, Tian L. Biofeedback-assisted relaxation training for essential hypertension. Who is most likely to benefit? J Cardiovasc Nurs 2005, 20: 198-205.
  26.  Cohen DL, Bloedon LT, Rothman R, et al. Iyengar Yoga versus enhanced usual care on blood pressure in patients with prehypertension to stage I hypertension: a randomized controlled trial. Evid Based Complement Alternat Med 2009, [Epub ahead of print]
  27.  Wexler R, Aukerman G. Nonpharmacologic strategies for managing hypertension. Am Fam Physician 2006, 73:1953-6, 1957-8.
  28.  Schneider RH, Alexander CN, Sheppard W, et al. A randomized controlled trial of stress reduction for hypertension in older Africans Americans. Hypertension 1995, 26:820-7.
  29.  Canter PH, Ernst E. Insufficient evidence to conclude whether or not transcendental meditation decreases blood pressure: results of a systematic review of randomized clinical trials. J Hypertens 2004, 22:2049-54.
  30.  Schneider RH, Alexander CN, Staggers F, et al. Long term effects of stress reduction on mortality in persons >or =55 years of age with systemic hypertension. Am J Cardiol 2005, 95: 1060-4. 
  31.  Canter PH. The therapeutic effects of neditation. BMJ 2003, 326:1049-50.
  32.  Barnes V, Schneider R, Alexander C, Staggers F. Stress, stress reduction, and hypertension in Africans Americans: An updated review. Natl Med Assoc 1997, 89:464-476.
  33.  Sandu JS, Berri A, Gupta D, et al. Essential hypertension-Primary prevention. JIACM 2004, 4:306-9.
  34.  Black HR. Non pharmacologic therapy for hypertension. Am J Med 1979, 66:837-842.
  35.  Crowther JH. Stress management training and relaxation imagery in the treatment of essential hypertension. J Behav Med 1982, 6:169-187.
  36.  Yung P, French P, Leung B. Relaxation training as complementary therapy for mild hypertension control and the implications of evidence-based medicine. Complement Ther in Nurs Midwifery 2001, 7:59-65.
  37.  Garcia-Vera MP, Labrador FJ, Sanz J. Stress-management training for essential hypertension: a controlled study. Appl Psychophysiol Biofeedback 1997, 22:261-283.
  38.  Knox S, Theorell T, Malmberg BG, Lindqvist R. Stress management in the treatment of essential hypertension in primary health care. Scand J Prim Health Care 1986, 3:175-181.
  39.  Agras WS, Horne M, Taylor CB. Expectation and blood pressure-lowering effects of relaxation. Psychosom Med 1982, 44:389-395.
  40.  Wadden TA. Relaxation therapy for essential hypertension: specific or nonspecific effects? J Psychosom Res 1984, 28:53-61.
  41.  Lucini D, Malacarne M, Solaro N, Busin S, Pagani M. Complementary medicine for the management of chronic stress: superiority of active versus passive techniques. J Hypertens 2009, 27: 2421-2428.
  42.  Batey DM, Kaufmann PG, Raczynski JM, et al. Stress management intervention for primary prevention of hypertension: detailed results from phase I of trials of hypertension prevention (TOHP-I). Ann Epidemiol 2000, 10(1):45-58.
  43.  Spence JD, Barnett PA, Linden W, et al. Recommendations on stress management. CMAJ 1999, 160:S46-S50.
  44.  D’Atri DA, Fitzgerald EF, Kasl SV, Ostfeld AM. Crowding in prison: the relationship between changes in housing mode and blood pressure. Psychosom Med 1981, 43:95-105.
  45.  Bosley F, Allen TW. Stress management training for hypertensives: cognitive and physiological effects. J Behav Med 1988, 12:77-89.
  46.  Chesney MA, Black GW, Swan GE, Ward MM. Relaxation training for essential hypertension at the worksite: I. The untreated mild hypertensive. Psychosom Med 1987, 49:250-263.
  47.  Goldstein IB, Shapiro D, Thananopavaran C. Home relaxation techniques for essential hypertension. Psychosom Med 1984, 46: 398-414.
  48.  Macleod J, Smith GD, Heslop P, Metcalfe C, Carroll D, Hart C. Are the effects of psychosocial exposures attributable to confounding? Evidence from a prospective observational study on psychological stress and mortality. J Epidemiol Community Health 2001, 55(12):878-84.
  49.  Parrott AC. Nesbitt’s Paradox resolved? Stress and arousal modulation during cigarette smoking. Addiction 1998, 93(1):27-39.
  50.  Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 2003, 129(2):270-304.
  51.  Parrott AC. Smoking cessation leads to reduced stress, but why? Int J Addict 1995, 30(11):1509-16.
  52.  Pomerleau OF, Pomerleau CS. Research on stress and smoking: progress and problems. Br J Addict 1991, 86(5):599-603.
  53.  Takeda E, Terao J, Nakaya Y, et al. Stress control and human nutrition. J Med Invest 2004, 51(3-4):139-45.
  54.  Sillaber I, Henniger MS. Stress and alcohol drinking. Ann Med 2004, 36(8):596-605.
  55.  Brady KT, Sonne SC. The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health 1999 23(4):263-71.
  56.  Silberman Y, Bajo M, Chappell AM, et al. Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions. Alcohol 2009, 43(7):509-19.
  57.  Uhart M, Wand GS. Stress, alcohol and drug interaction: an update of human research. Addict Biol 2009, 14(1):43-64.
  58.  Corrrigan M, Cupples ME, Smith SM,, et al. The contribution of qualitative research in designing a complex intervention for secondary prevention of coronary heart disease in two different healthcare systems. BMC Health Serv Res 2006, 6:90.
  59.  Nabi H, Vahtera J, Singh-Manoux A, et al. Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. J Hypertens 2008, 26(11):2236-43.
  60.  Cohen M, Kanter Y. Relation between sense of coherence and glycemic control in type 1 and type 2 diabetes. Behav Med 2004, 29(4):175-83.
  61.  George GC, Milani TJ, Hanss-Nuss H, Freeland-Graves JH. Compliance with dietary guidelines and relationship to psychosocial factors in low-income women in late postpartum. J Am Diet Assoc 2005, 105(6):916-26.
  62.  Chang MW, Nitzke S, Guilford E, Adair CH, Hazard DL. Motivators and barriers to healthful eating and physical activity among low-income overweight and obese mothers. J Am Diet Assoc 2008, 108(6):1023-8.
  63.  Gazmararian JA, Ziemer DC, Barnes C. Perception of barriers to self-care management among diabetic patients. Diabetes Educ 2009, 35(5):778-88.
  64.  DiGiacomo M, Davidson PM, Davison J, Moore L, Abbott P. Stressful life events, resources, and access: key considerations in quitting smoking at an Aboriginal Medical Service. Aust N Z J Public Health 2007, 31(2):174-6.
  65.  Mosca L, McGillen C, Rubenfire M., Gender differences in barriers to lifestyle change for cardiovascular disease prevention. J Womens Health 1998, 7(6):711-5.